Cargando…
Serum biomarkers of neuroinflammation and blood-brain barrier leakage in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is an incurable and rapidly progressive neurological disorder. Biomarkers are critical to understanding disease causation, monitoring disease progression and assessing the efficacy of treatments. However, robust peripheral biomarkers are yet to be identified. Neur...
Autores principales: | Cao, Maize C., Cawston, Erin E., Chen, Grace, Brooks, Collin, Douwes, Jeroen, McLean, Dave, Graham, E. Scott, Dragunow, Mike, Scotter, Emma L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188104/ https://www.ncbi.nlm.nih.gov/pubmed/35690735 http://dx.doi.org/10.1186/s12883-022-02730-1 |
Ejemplares similares
-
Transcriptional targets of amyotrophic lateral sclerosis/frontotemporal dementia protein TDP-43 – meta-analysis and interactive graphical database
por: Cao, Maize C., et al.
Publicado: (2022) -
Microglial CD68 and L-ferritin upregulation in response to phosphorylated-TDP-43 pathology in the amyotrophic lateral sclerosis brain
por: Swanson, Molly E. V., et al.
Publicado: (2023) -
Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
por: Rizzo, Federica, et al.
Publicado: (2013) -
Oxidative Stress, Neuroinflammation and Mitochondria in the Pathophysiology of Amyotrophic Lateral Sclerosis
por: Obrador, Elena, et al.
Publicado: (2020) -
Respiratory symptoms and use of dust-control measures in New Zealand construction workers – A cross-sectional study
por: Keer, Samuel, et al.
Publicado: (2022)